Mercados españoles cerrados

Fresenius SE & Co. KGaA (FRE.DE)

XETRA - XETRA Precio demorado. Divisa en EUR
Añadir a la lista de favoritos
26,90+0,25 (+0,94%)
Al cierre: 05:35PM CEST

Fresenius SE & Co. KGaA

Else-Kroener-Strasse 1
Bad Homburg vor der Höhe 61352
Germany
49 6172 6080
https://www.fresenius.com

Sector(es)Healthcare
SectorMedical Care Facilities
Empleados a tiempo completo193.865

Ejecutivos clave

NombreTítuloPagaEjecutadoAño de nacimiento
Mr. Michael SenCEO, President & Chairman of Management Board - Fresenius Management SE4,09MN/A1968
Ms. Sara Lisa HennickenCFO & Member of the Management Board - Fresenius Management SE1,55MN/A1980
Mr. Pierluigi AntonelliMember of Management Board of Fresenius Management SE & CEO of Fresenius Kabi2MN/AN/A
Dr. Michael Sven Moser Ph.D.Member of Management Board of Fresenius Management SE1,2MN/A1978
Mr. Robert MollerMember of the Management Board of Fresenius Management SE1,15MN/A1971
Mr. Markus GeorgiSenior Vice President of Investor RelationsN/AN/AN/A
Matthias LinkSenior Vice President Corporate CommunicationsN/AN/AN/A
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en EUR.

Descripción

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

Gobierno corporativo

El ISS Governance QualityScore de Fresenius SE & Co. KGaA, a día 1 de abril de 2024, es 2. Las puntuaciones base son Auditoría: 1; Tablero: 3; Derechos de los accionistas: 1; Compensación: 2.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.